A study presented at the American Heart Association Scientific Sessions indicates that using SGLT2 inhibitors or GLP-1 receptor agonists after a stroke might improve mortality and reduce the risk of heart attack and recurrent stroke. The findings were based on data for 7,044 adults who had an acute ischemic stroke.
Full Story: Healio (free registration) (12/13)